NEW YORK (AFX) - Neurochem Inc., which develops biopharmaceutical drugs, said Friday Ronald Nordmann has resigned from the company's board of directors.
Nordmann, who joined the board in 2002, acted as the lead director for two years, up to May of 2006.
The Canada-based company did not provide a reason for Nordmann's departure.
Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.